As. Friedmann et al., VASOPRESSIN AND OXYTOCIN PRODUCTION BY NON-NEUROENDOCRINE LUNG CARCINOMAS - AN APPARENT LOW INCIDENCE OF GENE-EXPRESSION, Cancer letters, 75(2), 1993, pp. 79-85
In previous studies we have demonstrated the high incidence of vasopre
ssin gene expression as a characteristic feature of small-cell carcino
ma of the lung. In the present study we examined expression of this ge
ne in non-neuroendocrine tumors to determine if vasopressin production
is a common feature of all lung tumors. We carried out the immunohist
ochemical evaluation of 22 non-neuroendocrine tumors (12 adenocarcinom
as and 10 squamous-cell carcinomas) with antibodies to vasopressin, to
oxytocin, and to their related neurophysins. The antibody preparation
s directed against vasopressin, oxytocin, or oxytocin-associated human
neurophysin did not react with any of the tumors examined. Of two mon
oclonal antibodies to vasopressin-associated human neurophysin used, o
ne did not react with any of the tumors, while the other stained neopl
astic cells in only one adenocarcinoma and one squamous-cell carcinoma
. These findings, taken with previous reports, indicate that among lun
g carcinomas, a high incidence of vasopressin/oxytocin gene expression
is confined to neuroendocrine tumors.